# OnCo record alex-herrera (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/alex-herrera/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "alex-herrera" ;
  schema:name "Alex F. Herrera"@en ;
  schema:description "Led the SWOG S1826 trial that made nivolumab part of first-line Hodgkin lymphoma treatment."@en ;
  schema:url <https://onco.cc/people/alex-herrera/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.cityofhope.org/research/find-a-researcher>, <https://pubmed.ncbi.nlm.nih.gov/?term=Herrera%20AF%5BAuthor%5D>, <https://scholar.google.com/scholar?q=Alex%20F.%20Herrera> ;
  schema:jobTitle "Chief, Division of Lymphoma, City of Hope; SWOG Executive Officer, Leukemia/Lymphoma/Myeloma" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/brentuximab-vedotin/> ;
  onco:companies <https://onco.cc/companies/swog/> ;
  onco:institutions <https://onco.cc/institutions/city-of-hope/> ;
  onco:trials <https://onco.cc/trials/swog-s1826/> ;
  onco:journals <https://onco.cc/journals/blood/> ;
  schema:affiliation <https://onco.cc/institutions/city-of-hope/> .